Wordt geladen...
VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity
Valtoco(®) is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older. Although IV and rectal diazepam are already used to treat seizure clusters, Valt...
Bewaard in:
| Gepubliceerd in: | Neurol Int |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7931041/ https://ncbi.nlm.nih.gov/pubmed/33670456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/neurolint13010007 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|